Form 4: Labcorp Executive Reports Stock Transactions
Insider Transaction Report
Labcorp's EVP of Corporate Affairs, Sandra D. van der Vaart, reported recent acquisitions and dispositions of common stock related to Restricted Stock Unit vesting and tax withholdings.
Summary
- Sandra D. van der Vaart, EVP, Corporate Affairs at Labcorp Holdings Inc. (LH), reported transactions involving the company's common stock.
- On February 6, 2026, 387 shares of common stock were acquired upon the vesting of Restricted Stock Units (RSUs).
- Following this acquisition, 101 shares were disposed of on February 6, 2026, at a price of $277.2 per share, to satisfy tax withholding obligations.
- On February 7, 2026, an additional 353 shares of common stock were acquired upon the vesting of RSUs.
- On February 9, 2026, 93 shares were disposed of at a price of $274.01 per share, also for tax withholding purposes.
- The amount of beneficially owned common stock changed from 2,690.4864 to 2,589.4864, then to 2,942.4864, and finally to 2,849.4864 shares.
- The reporting person also acquired 29.8173 shares on December 31, 2025, under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan, which is included in the reported beneficial ownership.
- As of the latest transaction, the reporting person holds 1,517 Restricted Stock Units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to executive compensation and tax obligations, which do not typically convey positive or negative sentiment about the company's operational or financial performance.
Positives
- Vesting of Restricted Stock Units indicates the executive is receiving equity compensation, aligning interests with shareholders.
- An acquisition of 29.8173 shares on December 31, 2025, under the Employee Stock Purchase Plan suggests continued participation in company equity programs.
Negatives
- Dispositions of common stock totaling 101 shares at $277.2 and 93 shares at $274.01 were made to satisfy tax withholding obligations, which is a routine event following RSU vesting and not indicative of a negative outlook.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that insider transaction reports like this Form 4 are common occurrences for publicly traded companies, reflecting routine equity compensation practices for executives. These transactions, particularly those involving RSU vesting and tax-related sales, are generally not indicative of broader industry trends or competitive positioning but rather standard executive compensation events.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Sandra D. van der Vaart granted a Power of Attorney to Kathryn W. Kyle to execute and file Forms 3, 4, and 5 on her behalf in accordance with Section 16(a) of the Securities Exchange Act of 1934. | 2026-01-06 | This is a standard corporate governance practice to facilitate timely and compliant SEC filings for insiders, ensuring adherence to regulatory requirements without requiring the executive's direct signature for each filing. |
Stakeholder Impact
- Shareholders: Minimal direct impact, as these are routine executive compensation transactions and tax-related sales, not indicative of a change in company fundamentals or strategy.
- Employees: The Employee Stock Purchase Plan mentioned indicates ongoing equity participation opportunities for employees.
Key Dates
| Date | Description |
|---|---|
| 2024-02-07 | Start of three equal annual installments for RSU vesting, now fully vested. |
| 2025-02-06 | Start of three equal annual installments for RSU vesting. |
| 2025-12-31 | Acquisition of 29.8173 shares under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan. |
| 2026-01-06 | Date of execution for the Power of Attorney granted to Kathryn W. Kyle. |
| 2026-02-06 | Acquisition of 387 common shares and disposition of 101 common shares for tax withholding; vesting of 387 Restricted Stock Units. |
| 2026-02-07 | Acquisition of 353 common shares upon vesting of Restricted Stock Units. |
| 2026-02-09 | Disposition of 93 common shares for tax withholding. |
| 2026-02-10 | Signature date of the Form 4 filing. |
Keywords
Labcorp Holdings Inc., LH, Insider Trading, Form 4, Restricted Stock Units, Equity Compensation, Stock Transactions, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.